Stress Test Evidence Rigour and Ethical Compliance
Evaluate the validation strategy against stringent clinical standards, regulatory expectations, and ethical frameworks. The founder subjects the artefact to expert critique to surface hidden biases, execution risks, and safety concerns.
Rigorous stress-testing ensures the validation plan withstands scrutiny from regulators, clinical buyers, and institutional investors. It minimises the risk of inconclusive results, protocol amendments, or ethical breaches during execution.
Present an updated risk register and evidence review log documenting all identified vulnerabilities, ethical risks, and expert feedback. Demonstrate explicit mitigation plans for each high-severity risk identified.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What biases could invalidate your trial results during execution?
- 2
How does your protocol handle patient data privacy, consent, and information governance compliance?
- 3
If your primary endpoint yields a statistically insignificant result, what is the venture's contingency plan?
- 4
How have you accounted for clinical site variability and operator error in your trial protocol?
- 5
What evidence do you have that clinical buyers will accept this trial design as sufficient proof for procurement?